B3-Läsionen der Mamma stellen eine heterogene Gruppe von Läsionen mit unsicherem
Malignitätspotenzial dar, welche histologisch klar definierte Diagnosen beinhalten und …

Fortschritte in der bildgebenden Brustdiagnostik und die Einführung von minimalinvasiven
Nadelbiopsien haben neben einer besseren Brustkrebsfrüherkennung auch die Zahl falsch …

B3 lesions comprise different histopathological entities that are considered benign but 'of
unknown biological potential'. These entities may act as risk indicators (for both breasts) or …

Methods: Between 2007-2010, 131 breast screening patients with B3 lesions on core
needle/vacuum assisted biopsy that subsequently underwent excisional biopsy were …

Breast needle core biopsy is a widely used technique for evaluation of mammographic and
clinical breast abnormalities, screen detected and symptomatic. The majority of biopsies can …

Background B3 breast lesions are a heterogeneous group with uncertain malignant
potential and, as such, provide a source of diagnostic difficulty. We calculated the …

Introduction The purpose of this study was to evaluate mammographic and magnetic
resonance imaging (MRI) features in B3 lesions. Patients and Methods From 2011 to 2018 …

Introduction Lesions of uncertain malignant potential (B3) represent 10% of core needle
biopsies (CNBs) or vacuum-assisted breast biopsies (VABBs). Traditionally, B3 lesions are …

Aims B3 lesions of the breast represent a difficult management dilemma. The umbrella term
'B3'incorporates lesions with little associated malignancy risk as well as lesions with …

Objectives To evaluate excision histology outcome of B3a lesions diagnosed at imaging-
guided core biopsy and assess whether clinical and radiologic features may predict upgrade …